WS-383

N/A

Report date: 2023/04/25 09:12:52
NME

Base Information

Drug NameWS-383
Drug Alias NameWS-383
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDCN1 and UBC12 interaction inhibitor
TargetsNEDD8-conjugating enzyme Ubc12DCN1-like protein 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhengzhou UniversityUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MichiganZhengzhou University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A